These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 10363620)
21. Pharmacodisposition of thiamphenicol in rabbits. Abd El-Aty AM; Abo El Sooud K; Goudah AM Dtsch Tierarztl Wochenschr; 2001 Sep; 108(9):393-6. PubMed ID: 11599443 [TBL] [Abstract][Full Text] [Related]
22. Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration. Goudah A; Abo El-Sooud K; Shim JH; Shin HC; Abd El-Aty AM J Vet Pharmacol Ther; 2008 Oct; 31(5):399-405. PubMed ID: 19000258 [TBL] [Abstract][Full Text] [Related]
23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
24. Bioavailability and metabolism of the flavonol quercetin in the pig. Ader P; Wessmann A; Wolffram S Free Radic Biol Med; 2000 Apr; 28(7):1056-67. PubMed ID: 10832067 [TBL] [Abstract][Full Text] [Related]
25. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871 [TBL] [Abstract][Full Text] [Related]
26. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia. Low BS; Ng BH; Choy WP; Yuen KH; Chan KL Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032 [TBL] [Abstract][Full Text] [Related]
27. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats. Li X; Choi JS Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats. Bohlooli S; Keyhanfar F; Mahmoudian M Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221 [TBL] [Abstract][Full Text] [Related]
29. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat. Zhang Y; Akao T; Nakamura N; Duan CL; Hattori M; Yang XW; Liu JX Planta Med; 2004 Feb; 70(2):138-42. PubMed ID: 14994191 [TBL] [Abstract][Full Text] [Related]
30. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Khaled KA; El-Sayed YM; Al-Hadiya BM Drug Dev Ind Pharm; 2003 Apr; 29(4):397-403. PubMed ID: 12737533 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications. Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140 [TBL] [Abstract][Full Text] [Related]
32. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics. Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720 [TBL] [Abstract][Full Text] [Related]
34. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats. Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347 [TBL] [Abstract][Full Text] [Related]
35. A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats. Boonpawa R; Spenkelink A; Rietjens IM; Punt A Biochem Pharmacol; 2014 May; 89(2):287-99. PubMed ID: 24561179 [TBL] [Abstract][Full Text] [Related]
37. Carbon dioxide is the major metabolite of quercetin in humans. Walle T; Walle UK; Halushka PV J Nutr; 2001 Oct; 131(10):2648-52. PubMed ID: 11584085 [TBL] [Abstract][Full Text] [Related]
38. Endogenous and exogenous mediators of quercetin bioavailability. Guo Y; Bruno RS J Nutr Biochem; 2015 Mar; 26(3):201-10. PubMed ID: 25468612 [TBL] [Abstract][Full Text] [Related]
39. Absorption of quercetin and rutin in rat small intestine. Carbonaro M; Grant G Ann Nutr Metab; 2005; 49(3):178-82. PubMed ID: 16006787 [TBL] [Abstract][Full Text] [Related]
40. Disposition of quercetin in man after single oral and intravenous doses. Gugler R; Leschik M; Dengler HJ Eur J Clin Pharmacol; 1975 Dec; 9(2-3):229-34. PubMed ID: 1233267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]